Effect of Soundscape Augmentation on Behavioral Symptoms in People With Dementia: A Pilot Randomized Controlled Trial

被引:0
作者
Talebzadeh, Arezoo [1 ]
Botteldooren, Dick [1 ]
Thomas, Pieter [1 ]
Stewart, Steven [4 ]
Van de Velde, Dominique [2 ]
De Vriendt, Patricia [2 ,3 ]
Devos, Paul [1 ]
Iaboni, Andrea [4 ,5 ]
机构
[1] WAVES Ghent Univ, Dept Informat Technol, Ghent, Belgium
[2] Univ Ghent, Fac Med & Hlth Care Sci, Dept Rehabil Sci, Occupat Therapy Res Grp, Ghent, Belgium
[3] Artevelde Univ Appl Sci, Occupat Therapy Dept, Ghent, Belgium
[4] Univ Hlth Network, KITE Toronto Rehabil Inst, Toronto, ON, Canada
[5] Univ Toronto, Temerty Fac Med, Dept Psychiat, Toronto, ON, Canada
关键词
Neuropsychiatric symptoms; sound environment; Nonphamacological interventions; SCALE; AGITATION; ENVIRONMENTS; IMPAIRMENT; THERAPY;
D O I
10.1093/geroni/igae069
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background and Objectives: Sound is an important environmental factor that influences the expression of behavioral and psychological symptoms of dementia. Recent research on the effect of soundscape has shown promising results in improving environmental impact on people with dementia. However, no controlled studies have aimed to quantify the effects of soundscape intervention on resident outcomes. The aim of this study was to assess the feasibility and impact of a soundscape intervention on people with dementia and behavioral symptoms. Research Design and Methods: Pilot single-blind repeated-measures randomized controlled trial of an augmented soundscape intervention. Participants were people with dementia in a hospital-based specialized dementia unit. Participants were randomized to an augmented soundscape intervention delivered in their room in the morning and evening or treatment as usual, with 2 baseline weeks and 4 weekly post-randomization assessments of the primary and secondary behavioral outcomes. Results: The soundscape intervention was feasible in terms of recruitment, retention, and delivery of the intervention. There were improvements in the neuropsychiatric inventory total scores over time in both groups (-5.89, 95%CI -8.45 to -3.28, p < .001), but no differences between groups. There were no significant group, time, or group x time differences for the Pittsburgh Agitation Scale (PAS) total score. For the PAS-resisting care subscale, there was a significant group x time difference, with a greater reduction in the soundscape group over the study period (-0.81, 95% CI -1.59 to -0.03, p = .042). Discussion and Implications: In this pilot study, soundscape augmentation was a feasible and effective nonpharmacological approach to reducing resistance to care in people with dementia, although it did not improve neuropsychiatric symptoms more globally. Further studies with larger samples and of longer duration are needed to investigate the long-term effects of augmented sonic environments on people with dementia.
引用
收藏
页数:10
相关论文
共 48 条
  • [1] Models for skin and brain penetration of major components from essential oils used in aromatherapy for dementia patients
    Agatonovic-Kustrin, Snezana
    Chan, Chloe Ke Yi
    Gegechkori, Vladimir
    Morton, David W.
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (08) : 2402 - 2411
  • [2] Awareness of "sound' in nursing homes: A large-scale soundscape survey in Flanders (Belgium)
    Aletta, Francesco
    Vander Mynsbrugge, Tara
    Van de Velde, Dominique
    De Vriendt, Patricia
    Thomas, Pieter
    Filipan, Karlo
    Botteldooren, Dick
    Devos, Paul
    [J]. BUILDING ACOUSTICS, 2018, 25 (01) : 43 - 59
  • [3] Monitoring Sound Levels and Soundscape Quality in the Living Rooms of Nursing Homes: A Case Study in Flanders (Belgium)
    Aletta, Francesco
    Botteldooren, Dick
    Thomas, Pieter
    Vander Mynsbrugge, Tara
    De Vriendt, Patricia
    Van de Velde, Dominique
    Devos, Paul
    [J]. APPLIED SCIENCES-BASEL, 2017, 7 (09):
  • [4] Andringa T. C., 2013, INT NOIS CON C C P P, P1
  • [5] [Anonymous], 2014, ISO12913-1
  • [6] Brown Juliette, 2016, BMJ Qual Improv Rep, V5, DOI 10.1136/bmjquality.u207447.w4214
  • [7] A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer's Disease
    Burns, Alistair
    Perry, Elaine
    Holmes, Clive
    Francis, Paul
    Morris, Julie
    Howes, Melanie-Jayne R.
    Chazot, Paul
    Lees, George
    Ballard, Clive
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (02) : 158 - 164
  • [8] Bright light therapy for agitation in dementia: a randomized controlled trial
    Burns, Alistair
    Allen, Harry
    Tomenson, Barbara
    Duignan, Debbie
    Byrne, Jane
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2009, 21 (04) : 711 - 721
  • [9] The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia
    de Medeiros, K.
    Robert, P.
    Gauthier, S.
    Stella, F.
    Politis, A.
    Leoutsakos, J.
    Taragano, F.
    Kremer, J.
    Brugnolo, A.
    Porsteinsson, A. P.
    Geda, Y. E.
    Brodaty, H.
    Gazdag, G.
    Cummings, J.
    Lyketsos, C.
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (06) : 984 - 994
  • [10] Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review
    de Oliveira, Alexandra Martini
    Radanovic, Marcia
    Homem de Mello, Patricia Cotting
    Buchain, Patricia Cardoso
    Barbosa Vizzotto, Adriana Dias
    Celestino, Diego L.
    Stella, Florindo
    Piersol, Catherine V.
    Forlenza, Orestes V.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015